On March 27-29, 2015, at the Hilton Clearwater Beach, Clearwater Beach, FL, ACMT held its 2015 Annual Scientific Meeting. The recorded lectures are featured below. All require registration to view but the lectures with the "Watch Now" button are provided complimentary. If you were a registered attendee at this conference, you can access these lectures by emailing firstname.lastname@example.org and we will provide you a passcode.
- Discuss how the many aspects of prevention can be applied in medical toxicology, from the individual patient at the bedside to the population at large.
- Review ongoing initiatives and advances in prevention related to all aspects of toxicology and discuss the unintended consequences of these techniques.
Presidential Keynote: Opportunities and Challenges for Medical Toxicology in the Emerging Value-Based Health Care Economy
Kenneth W. Kizer, MD, MPH, FACMT, Director, Institute for Population Health Improvement, UC Davis Health System, and Distinguished Professor, UC Davis School of Medicine (Department of Emergency Medicine) and the Betty Irene Moore School of Nursing
- Review the key characteristics and objectives of the new value-based models of health care payment.and how these differ from fee for service.
- Describe at least two of the currently used value-based models of health care payment.
- Explain what is meant by integrated care delivery.
- Discuss at least three generic ways that medical toxicologists can support and play a role in the new value-based health care payment models.
Does Naloxone Really Raise Lazarus from the Dead?
Steven E. Aks, DO, FACMT
The Toxikon Consortium, Chicago, IL
Preventing Medication Exposures in Young Children: The Intersection of Medical Toxicology and Injury Prevention
Dan Budnitz, MD, MPH, CAPT,USPHS, Medication Safety Program, Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention
- Identify specific prevention targets in pediatric medication exposures.
- Apply principles of injury prevention to developing a prevention strategy for pediatric medication exposures.
- Discuss lessons learned from other injury prevention campaigns.
Choosing Wisely in Medical Toxicology
Anne Michelle Ruha, MD, FACMT
Banner Good Samaritan Medical Center, Phoenix, AZ
The Science Behind Package Insert Labeling
Kellie Schoolar Reynolds, PharmD
Division of Clinical Pharmacology IV (DCPIV), Food and Drug Administration
- Review the goals and format of the package label.
- Discuss barriers to clear instructions, specifically theoretical vs data driven information and risk assessment.
- Review the process behind label updates with examples.
- Examine the preventative measures and recommendations for at risk patients regarding diet and food contaminants.
- Discuss the current evidence regarding the toxicity of genetically modified foods, pesticide residues, and food additives.